Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 13Dermatologic 1

Conditions

Melanoma 112Carcinoma, Non-Small-Cell Lung 26Skin Neoplasms 20Colorectal Neoplasms 17Sarcoma 15Lung Neoplasms 15Carcinoma, Renal Cell 15Breast Neoplasms 14Squamous Cell Carcinoma of Head and Neck 13Pancreatic Neoplasms 13Ovarian Neoplasms 13Carcinoma, Merkel Cell 12Urinary Bladder Neoplasms 11Prostatic Neoplasms 11Neoplasms 11Carcinoma, Basal Cell 11Stomach Neoplasms 10Neoplasm Metastasis 10Head and Neck Neoplasms 10Carcinoma, Hepatocellular 10Uterine Cervical Neoplasms 8Thyroid Neoplasms 8Lymphoma, T-Cell, Cutaneous 8Mycosis Fungoides 7Esophageal Neoplasms 7Brain Neoplasms 7Recurrence 6Lymphoma, Large-Cell, Anaplastic 6Lymphoma 6Gastrointestinal Neoplasms 6

Interventions

cabozantinib 1Specimen Handling 1Nivolumab 1Magnetic Resonance Spectroscopy 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Laryngeal Neoplasms × Dermatologic × 30 days × Clear all
NCT05136196 2026-06-05

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

National Cancer Institute (NCI)

Phase 2 Recruiting
150 enrolled
DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Melanoma, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡